You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AZD4547

Showing 1 - 18 of 18
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Urothelial Carcinoma Trial in Shanghai (AZD4547, Tislelizumab)

Recruiting
  • Urothelial Carcinoma
  • Shanghai, Shanghai, China
    Fudan University Shanghai Cancer Center
Mar 8, 2023

Breast Cancer Trial in United Kingdom (AZD4547 / anastrozole or letrozole)

Completed
Has Results
  • Breast Cancer
  • AZD4547 / anastrozole or letrozole
  • Burton-on-Trent, Staffs, United Kingdom
  • +6 more
Apr 20, 2022

Urothelial Carcinoma Trial in Shanghai (AZD4547)

Recruiting
  • Urothelial Carcinoma
  • AZD4547
  • Shanghai, Shanghai, China
    Fudan University Cancer Hospital
Oct 20, 2021

Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (FGFR Inhibitor

Completed
Has Results
  • Advanced Lymphoma
  • +5 more
  • FGFR Inhibitor AZD4547
  • Philadelphia, Pennsylvania
    ECOG-ACRIN Cancer Research Group
Jun 8, 2021

Health, Subjective, Food-drug Interaction Trial in Taipei (ABSK091 tablet)

Completed
  • Health, Subjective
  • Food-drug Interaction
  • ABSK091 tablet
  • Taipei, Taiwan
    Tri-Service General Hospital
Sep 5, 2022

Muscle Invasive Bladder Cancer Trial in Worldwide (AZD4547, MEDI4736, Olaparib)

Active, not recruiting
  • Muscle Invasive Bladder Cancer
  • AZD4547
  • +6 more
  • Los Angeles, California
  • +26 more
Oct 17, 2022

NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Non-small Cell Lung Cancer Metastatic
  • Avignon, France
  • +36 more
Jul 29, 2022

Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)

Active, not recruiting
  • Metastatic Breast Cancer
  • Angers, France
  • +24 more
Mar 8, 2022

NSCLC, Carcinoma, Squamous Cell, Adenocarcinoma Trial in United Kingdom (AZD4547, Vistusertib, Palbociclib)

Active, not recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • AZD4547
  • +10 more
  • Aberdeen, United Kingdom
  • +24 more
Nov 2, 2021

FGFR1 Gene Amplification, FGFR1 Gene Mutation, FGFR2 Gene Amplification Trial in Canada, United States (Docetaxel, FGFR

Completed
Has Results
  • FGFR1 Gene Amplification
  • +7 more
  • Birmingham, Alabama
  • +1083 more
May 25, 2021

Cancer, Advanced Solid Malignancies Trial in Worldwide (AZD4547)

Terminated
Has Results
  • Cancer
  • Advanced Solid Malignancies
  • AZD4547
  • Stanford, California
  • +28 more
Nov 30, 2018

Treating Recurrent Stage IV Squamous Cell Lung Cancer

Active, not recruiting
  • Recurrent Squamous Cell Lung Carcinoma
  • Stage IV Squamous Cell Lung Carcinoma AJCC v7
  • Birmingham, Alabama
  • +1003 more
Nov 29, 2021

Recurrent NSCLC, Squamous Cell Lung Cancer Trial in United States (docetaxel, AZD4547)

Completed
Has Results
  • Recurrent Non-small Cell Lung Cancer
  • Squamous Cell Lung Cancer
  • Atlanta, Georgia
  • +4 more
Jan 26, 2018

Advanced Malignant Solid Tumor, Bladder Carcinoma, Breast Carcinoma Trial in Guam, Puerto Rico, United States (drug, procedure,

Recruiting
  • Advanced Malignant Solid Neoplasm
  • +49 more
  • Birmingham, Alabama
  • +1429 more
Aug 17, 2022

Gastro-oesophageal Junction Cancer, Gastric Cancer Trial in Worldwide (AZD4547, paclitaxel)

Terminated
Has Results
  • Gastro-oesophageal Junction Cancer
  • Gastric Cancer
  • Brussels (Anderlecht), Belgium
  • +60 more
Jan 16, 2017

Cancer, Advanced Solid Malignancies Trial in Chuo-ku, Nagoya-shi, Sapporo-shi (AZD4547)

Completed
  • Cancer
  • Advanced Solid Malignancies
  • AZD4547
  • Chuo-ku, Japan
  • +2 more
Jun 28, 2016

FGFR Inhibition, Pharmacokinetics, Biomarkers, ER+ Breast Cancer Trial in Worldwide (AZD4547, Exemestane, Placebo)

Completed
Has Results
  • FGFR Inhibition, Pharmacokinetics, Biomarkers
  • ER+ Breast Cancer
  • AZD4547
  • +3 more
  • Leuven, Belgium
  • +20 more
Jan 13, 2016

Gastric Cancer, Oesophageal Cancer, Breast Cancer Trial in London and Surrey (AZD 4547)

Unknown status
  • Gastric Cancer
  • +3 more
  • AZD 4547
  • London and Surrey, Surrey, United Kingdom
    Royal Marsden NHS Foundation Trust
Mar 14, 2013